Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/28/2012CA2821480A1 2-carboxamide-4-piperazinyl-benzofuran derivative
06/28/2012CA2821382A1 Phosphomycin pharmaceutical composition
06/28/2012CA2821378A1 Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
06/28/2012CA2821315A1 Novel multicomponent crystals made of ([2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and an arylpropionic acid
06/28/2012CA2821311A1 Novel multicomponent crystals made of ([2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and 2-[2-[(2,6-dichlorophenyl)-amino]-phenyl] acetic acid
06/28/2012CA2821230A1 Pharmaceutical compositions of pyridinium and quinolinium derivatives
06/28/2012CA2820877A1 Novel 19-nor-steroids and their use for treating progesterone-dependent conditions
06/28/2012CA2820448A1 2-amino-4-arylthiazole compounds as trpa1 antagonists
06/28/2012CA2820437A1 Pharmaceutical composites of poorly water soluble drugs and polymers
06/28/2012CA2820135A1 Diarylpyridazinone derivatives, preparation thereof, and use thereof for the treatment of humans
06/28/2012CA2819961A1 Novel fused pyridine compounds as casein kinase inhibitors
06/28/2012CA2819825A1 Compositions and methods for modulating fxr
06/28/2012CA2819299A1 N-substituted azetidine derivatives
06/28/2012CA2819175A1 5,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives useful as inhibitors of beta-secretase (bace)
06/28/2012CA2819041A1 Cyclic nucleotide analogs
06/28/2012CA2818623A1 Novel antifungal 5,6-dihydro-4h-pyrrolo[1,2-.alpha.][1,4]- benzodiazepines and 6h-pyrrolo[1,2-.alpha.][1,4]benzodiazepines substituted with bicyclic benzene derivatives
06/28/2012CA2818597A1 Quinoxalines and aza-quinoxalines as crth2 receptor modulators
06/28/2012CA2817688A1 Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient
06/28/2012CA2817524A1 Pharmaceutical formulations containing corticosteroids for topical administration
06/28/2012CA2817453A1 Aqueous solution of ambroxol
06/28/2012CA2762340A1 Compositions and methods for treating joints
06/27/2012EP2468868A1 Chemotherapeutic sensitizers
06/27/2012EP2468865A1 Antisense oligonucleotide modulation of stat3 expression
06/27/2012EP2468864A1 Nucleic acid compounds for inhibiting VEGF family gene expression and uses thereof
06/27/2012EP2468861A1 Method of constructing gene transport support
06/27/2012EP2468762A1 Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size
06/27/2012EP2468761A1 Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof
06/27/2012EP2468752A1 Thiazolopyridine derivatives as sirtuin-modulators
06/27/2012EP2468748A1 Pyrazoloquinolones are potent parp inhibitors
06/27/2012EP2468747A1 2-Selenophene-4-quinolones as anticancer agents
06/27/2012EP2468746A1 Benzothiazinone compounds and their use as anti-tuberculosis agents
06/27/2012EP2468745A1 Process for the preparation of lapatinib and the salts thereof
06/27/2012EP2468744A2 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
06/27/2012EP2468743A1 Nitrogen-containing bicyclic compounds useful as antibacterial agents
06/27/2012EP2468741A1 Novel quercetin derivatives, their preparation, pharmaceutical compositions containing them and their use
06/27/2012EP2468737A1 Sulfone derivative
06/27/2012EP2468736A1 Synthesis of intermediates for preparing anacetrapib and derivates thereof
06/27/2012EP2468735A1 Synthesis of intermediates for preparing anacetrapib and derivates thereof
06/27/2012EP2468734A1 Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry
06/27/2012EP2468732A1 1H-Quinazoline-2,4-diones
06/27/2012EP2468730A1 Substituted hydrazide compounds and application thereof
06/27/2012EP2468729A1 Novel indazole derivative
06/27/2012EP2468728A1 2-(1-phenyl-4,5,6,7-tetrahydro-1H-indazol-4-YL)ethylamine derivatives useful as sigma receptor inhibitors
06/27/2012EP2468726A1 Compound for the treatment of tumours and tumour metastases
06/27/2012EP2468724A1 Synthesis of pyrrolidine compounds
06/27/2012EP2468718A1 Cabanillasin, a new antifungal compound, produced by entomopathogenic xenorhabdus cabanillasii
06/27/2012EP2468711A2 Facially amphiphilic polyaryl and polarylalkynyl polymers and oligomers and uses thereof
06/27/2012EP2468318A1 Methods and products for treatment of diseases
06/27/2012EP2468303A1 Functionalized nucleic acids and particles comprising them for the treatment of HIV infections
06/27/2012EP2468283A1 Composition for treating or preventing cell degeneration
06/27/2012EP2468282A2 Methods and products for treatment of diseases
06/27/2012EP2468281A1 Quinoline derivative-containing pharmaceutical composition
06/27/2012EP2468280A1 Use of prokineticin 1 receptor agonists to promote the differentiation of epicardin+ progenitor cells
06/27/2012EP2468279A1 Prokineticin 1 receptor agonists and their uses
06/27/2012EP2468278A1 Controlled release oral formulations of ion channel modulating compounds and related methods for preventing arrhythmia
06/27/2012EP2468277A1 Triptolide derivatives for modulation of apoptosis and immunosuppression
06/27/2012EP2468276A1 Nitrostyrene derivatives having antimicrobial action
06/27/2012EP2468275A1 Nitrostyrenederivatives with antimicrobial action
06/27/2012EP2468274A1 Transdermal therapeutic system for application of an agent
06/27/2012EP2468273A2 Method to reduce oxidative damage and improve mitochondrial efficiency
06/27/2012EP2468272A1 Methods of treating a neurological disorder with creatine monohydrate
06/27/2012EP2468271A1 Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia
06/27/2012EP2468270A1 (R)-2-(3-fluoro-4-phenylphenyl)propionic acid for use in the treatment of skin diseases
06/27/2012EP2468269A1 Nitric oxide donors in therapy of nitric oxide deficiency-induced disturbances of cerebral microcirculation
06/27/2012EP2468268A1 Combination composition of vildagliptin and gliclazide
06/27/2012EP2468267A1 Bilayer Combination Composition of Vildagliptin and Gliclazide
06/27/2012EP2468266A2 Pharmaceutical compositions for acute glucocorticoid therapy
06/27/2012EP2468265A2 Homogeneous preparations containing vitamin D
06/27/2012EP2468264A1 Oral pharmaceutical tablet for controled release of mesalazine and process for obtaining it
06/27/2012EP2468261A1 Formulation of lacosamide
06/27/2012EP2468259A1 Pharmaceutical compositions of pyridinium and quinolinium derivatives
06/27/2012EP2468258A1 Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient
06/27/2012EP2468257A2 Injectable composition containing hydroxychloroquine for local administration for treating hemorrhoids
06/27/2012EP2468256A1 Combinations of vildagliptin and glimepiride
06/27/2012EP2468254A1 Orally disintegrating tablet having a taste masking effect
06/27/2012EP2468253A1 Terpenoid spiro ketal compounds with LXR agonists activity, their use and formulations with them
06/27/2012EP2468111A1 Compositions and applications of carotenoids of improved absorption and bioavailability
06/27/2012EP2468096A1 Anthelmintic combinations
06/27/2012EP2468094A1 Composition and methods for modulation of vascular structure and/or function
06/27/2012EP2467715A1 Riboflavin based aerosol and use as placebo in trials
06/27/2012EP2467483A1 Dna ligands for aflatoxin and zearalenone
06/27/2012EP2467482A2 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip
06/27/2012EP2467480A1 Treatment of patients after stent implantation or balloon dilatation and drug eluting stents
06/27/2012EP2467473A2 Ketoreductase polypeptides for the preparation of phenylephrine
06/27/2012EP2467465A1 Alcoholic compositions having a lowered risk of acetaldehydemia
06/27/2012EP2467398A1 Trp inhibitors and uses thereof
06/27/2012EP2467387A1 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
06/27/2012EP2467385A1 Renin inhibitors
06/27/2012EP2467383A1 Heterocyclic oxime compounds
06/27/2012EP2467382A1 Amino tetrahydro-pyridopyrimidine pde10 inhibitors
06/27/2012EP2467381A1 Substituted (thiazolyl-carbonyl)imidazolidinones and use thereof for treating retroviral diseases
06/27/2012EP2467380A2 Substituted benzoazepines as toll-like receptor modulators
06/27/2012EP2467379A1 Process for the production of coevaporates and complexes comprising voriconazole and cyclodextrin
06/27/2012EP2467378A2 Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same
06/27/2012EP2467377A2 Substituted benzoazepines as toll-like receptor modulators
06/27/2012EP2467376A1 Bicyclic heteroaryl inhibitors of pde4
06/27/2012EP2467375A1 Forms of dexlansoprazole and processes for the preparation thereof
06/27/2012EP2467373A2 A process for the synthesis of naratriptan
06/27/2012EP2467372A1 Treatment of bdnf-related disorders using laquinimod
06/27/2012EP2467368A1 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazine derivatives
1 ... 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 ... 7860